Breaking News, Financial News

Financial Results: Patheon 4Q12

CMO revenues up 18% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 4Q Revenues: $210.0 million (flat)  4Q Loss: $23.1 million (loss of $9.9 million in 4Q11) YTD Revenues: $749.1 million (+7%) YTD Loss: $106.7 million (loss of $16.4 million YTD11) Comments: Commercial manufacturing revenues in the quarter were $172.7 million, up 18%, and for the year were $610.7 million, up 7%. Pharmaceutical Development Services revenues in the quarter were $37.5 million, up 7%, and for the year were $138.4 million, up 9%. The loss before discontinued operations w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters